Figure 6E shows the three immune cells most strongly associated with the expression of AP006284.1, BCRP3, and AL35999.1, implying that AP006284.1, BCRP3, and AL35999.1 are key factors in the efficacy of PCa immunotherapy. Here, BCRP3 is linked to posterior cortical atrophy.